APA

Mancini M., De Santis S., Monaldi C., Bavaro L., Martelli M., Castagnetti F., Gugliotta G., Rosti G., Santucci M. A., Martinelli G., Cavo M. & Soverini S. (20191125). Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors. : Journal of experimental & clinical cancer research : CR.

Chicago

Mancini M, De Santis S, Monaldi C, Bavaro L, Martelli M, Castagnetti F, Gugliotta G, Rosti G, Santucci M A, Martinelli G, Cavo M and Soverini S. 20191125. Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors. : Journal of experimental & clinical cancer research : CR.

Harvard

Mancini M., De Santis S., Monaldi C., Bavaro L., Martelli M., Castagnetti F., Gugliotta G., Rosti G., Santucci M. A., Martinelli G., Cavo M. and Soverini S. (20191125). Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors. : Journal of experimental & clinical cancer research : CR.

MLA

Mancini M, De Santis S, Monaldi C, Bavaro L, Martelli M, Castagnetti F, Gugliotta G, Rosti G, Santucci M A, Martinelli G, Cavo M and Soverini S. Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors. : Journal of experimental & clinical cancer research : CR. 20191125.